Advertisement

Hemangiosarcoma in Dogs: Symptoms, Treatment & Prognosis

Understanding hemangiosarcoma in dogs: causes, symptoms, treatment options, and when to say goodbye.

By Sneha Tete, Integrated MA, Certified Relationship Coach
Created on

What is Hemangiosarcoma in Dogs?

Hemangiosarcoma (HSA) is a highly aggressive, malignant cancer that develops from the cells lining blood vessels in dogs. This devastating disease occurs when abnormal cells multiply rapidly in the endothelium—the inner lining of blood vessels—and can develop in various locations throughout the body. The disease is particularly insidious because it often remains undetected until it reaches an advanced stage, making early diagnosis challenging for pet owners and veterinarians alike.

This cancer is most commonly found in the spleen, heart, and skin, though it can develop anywhere in the body where blood vessels are present. The aggressive nature of hemangiosarcoma means that even when detected and treated, the disease frequently spreads to other organs including the lungs, brain, spine, and liver. Dogs diagnosed with hemangiosarcoma face a difficult prognosis, as the disease progresses rapidly and metastasis (spread to other parts of the body) is common.

Which Dogs Are Most at Risk?

While hemangiosarcoma can affect dogs of any age or breed, certain breeds show a higher predisposition to developing this cancer. Golden Retrievers, German Shepherds, and Labrador Retrievers are among the breeds most frequently diagnosed with hemangiosarcoma, though the exact reason for this genetic susceptibility remains unclear.

Middle-aged and senior dogs are at greatest risk, with most cases occurring in dogs over seven years of age. Male dogs may be slightly more susceptible than females, though hemangiosarcoma affects both sexes. The disease appears to develop spontaneously without a clear preventive factor, making it difficult for owners to reduce their dog’s risk through lifestyle modifications.

Recognizing the Symptoms of Hemangiosarcoma

One of the most challenging aspects of hemangiosarcoma is that dogs often show no clinical signs or only mild, non-specific symptoms in the early stages. This delayed presentation means the disease frequently progresses to an advanced stage before diagnosis. Pet owners should remain vigilant for the following warning signs:

  • Lethargy and weakness: Dogs may seem unusually tired, lack their normal energy, and show less interest in activities they once enjoyed
  • Loss of appetite: A decreased interest in food or refusal to eat can indicate systemic illness
  • Exercise intolerance: Dogs may tire quickly during walks or play sessions
  • Pale gums: A sign of anemia or reduced blood circulation, indicating potential internal bleeding
  • Collapse or fainting: Dogs may suddenly collapse, which can be a sign of internal bleeding or advanced disease
  • Difficulty breathing: If the cancer has spread to the lungs, dogs may have trouble breathing or develop a persistent cough
  • Abdominal distension: Swelling in the abdomen may indicate internal bleeding or fluid accumulation
  • Sudden death: In some cases, hemangiosarcoma presents as a sudden, life-threatening emergency with little warning[10]

The unpredictable nature of hemangiosarcoma means that seemingly healthy dogs can deteriorate rapidly. Pet owners who notice any combination of these symptoms should contact their veterinarian immediately, as prompt evaluation may provide more treatment options.

Diagnosis and Staging

Diagnosing hemangiosarcoma requires a combination of clinical examination, imaging studies, and sometimes biopsy. When a veterinarian suspects hemangiosarcoma based on symptoms and physical examination, they typically recommend imaging such as ultrasound or CT scans to visualize the tumor and check for metastasis to other organs.

A definitive diagnosis often requires a biopsy, where a small tissue sample is collected and examined under a microscope by a veterinary pathologist. This histopathological examination confirms whether the tumor is hemangiosarcoma and helps determine if it is benign or malignant—information that significantly impacts treatment decisions and prognosis.

Staging involves determining the extent of cancer spread throughout the body. Complete staging includes imaging of the chest, abdomen, and sometimes the brain to identify metastatic lesions. The stage of disease at diagnosis greatly influences treatment options and expected survival time.

Treatment Options for Hemangiosarcoma

Treatment for hemangiosarcoma varies depending on the tumor’s location, size, extent of metastasis, and the dog’s overall health status. Pet owners should understand that while several treatment options exist, hemangiosarcoma remains a serious condition with significant challenges.

Surgical Intervention

Surgery is considered the primary treatment method for most dogs with hemangiosarcoma. The goal of surgical intervention is to remove the primary tumor before it ruptures and causes life-threatening internal bleeding, or to remove the tumor if it has already ruptured.

Advantages of surgery include:

  • Immediate cessation of bleeding if the tumor has ruptured
  • Potential for cure if the tumor is found to be benign upon biopsy
  • Removal of the source of potential future bleeding episodes
  • Prevention of emergency situations caused by tumor rupture

Limitations and challenges:

  • In most cases, hemangiosarcoma has already spread to other organs (spleen, heart, lungs, spine, or brain) by the time of diagnosis
  • New tumors frequently develop and bleed in other locations after surgery
  • Average survival time after surgery alone is less than three months without additional treatment
  • Recovery from surgery typically requires two weeks, and this recovery period may not significantly extend quality of life unless the tumor is benign
  • Surgery is rarely feasible for tumors located on the heart

Specific surgical procedures depend on tumor location. For splenic hemangiosarcoma, a splenectomy (complete removal of the spleen) is typically performed. The spleen can be completely removed without compromising a dog’s long-term health, and this surgery successfully addresses bleeding from splenic hemangiosarcoma.

Chemotherapy

Chemotherapy is frequently recommended after surgery to delay cancer metastasis and improve survival time. When combined with surgery, chemotherapy can extend survival time to approximately six months on average, with some dogs living longer.

Standard chemotherapy protocol:

The standard chemotherapy regimen consists of doxorubicin (also called Adriamycin), an intravenous medication administered once every 2-3 weeks for a total of five treatments. This drug is well-tolerated in dogs, as the dosages used in veterinary oncology differ from those in human cancer treatment and generally produce fewer adverse effects.

Benefits of chemotherapy:

  • Can extend survival time when combined with surgery to approximately 6 months on average
  • Most dogs tolerate chemotherapy very well with minimal side effects
  • May delay the progression of metastatic disease
  • Can improve quality of life after initial recovery from surgery
  • Dogs receiving chemotherapy typically maintain good quality of life during treatment

Considerations and limitations:

  • Chemotherapy is not a long-term cure for hemangiosarcoma
  • Requires frequent veterinary visits for administration and monitoring
  • Can be costly, representing a significant financial investment
  • Potential side effects include nausea and loss of appetite in some dogs
  • Less effective if metastatic disease is already present at diagnosis

Additional chemotherapy agents or combinations may be recommended in some cases, and your veterinary oncologist will determine the most appropriate protocol based on your dog’s specific situation.

Radiation Therapy

Radiation therapy may be recommended in certain situations, particularly for cardiac hemangiosarcoma or cutaneous (skin) hemangiosarcoma with compromised surgical margins. Radiation can help reduce pain, manage bleeding, and slow tumor progression, though it is primarily used as a palliative (comfort-focused) treatment rather than a curative approach.

Palliative and Supportive Care

When surgery and chemotherapy are not feasible or appropriate—such as in cases of extensive metastatic spread—palliative care focuses on maintaining quality of life and managing symptoms.

Palliative treatment options include:

  • Yunnan Baiyao: A Chinese herbal supplement that some evidence suggests may help slow or reduce bleeding in dogs with hemangiosarcoma, though research is limited
  • Pain management: Medications such as gabapentin or other analgesics help manage discomfort
  • Anti-bleeding medications: May help minimize hemorrhage
  • Procedures to remove fluid: Drainage procedures can remove accumulation of fluid around the heart, in the chest, or abdomen
  • Blood transfusions: May be necessary if bleeding causes severe anemia
  • Anti-arrhythmic drugs: Help manage heart rhythm abnormalities
  • Bioactive mushroom extracts: Some holistic approaches may support immune function
  • Acupuncture: May help relieve pain and improve mobility

Prognosis and Survival Expectations

The prognosis for hemangiosarcoma in dogs is unfortunately poor, as this is one of the most aggressive cancers affecting canines. Without treatment, dogs with hemangiosarcoma typically survive only a few weeks after diagnosis. With treatment, survival times extend, but the disease remains fatal in the vast majority of cases.

Expected survival times vary by treatment approach:

  • Surgery alone: Average survival of less than 3 months
  • Surgery combined with chemotherapy: Average survival of approximately 6 months, with some dogs surviving longer
  • Palliative care without surgery: Weeks to a few months depending on disease progression

Prognosis varies somewhat by tumor location. Cutaneous (skin) hemangiosarcoma may have a better prognosis if confined to the skin and completely removed surgically. However, if the skin form extends deeply into muscle, it behaves as aggressively as splenic and cardiac forms. Hemangiosarcoma of the heart carries a similarly poor prognosis to splenic disease.

Managing End-of-Life Care and Making Euthanasia Decisions

Deciding when to say goodbye to a beloved pet with hemangiosarcoma is one of the most difficult decisions pet owners face. The unpredictable nature of the disease means many families must choose between emergency euthanasia during a crisis or euthanasia while their dog is still doing relatively well at home.

Many veterinarians recommend considering euthanasia proactively before symptoms become severe, as hemangiosarcoma often ends in a sudden crisis that leaves little time for peaceful goodbyes.

Indicators that it may be time for euthanasia include:

  • Difficulty breathing or excessive coughing: If cancer has spread to the lungs and the cough is frequent or difficult to manage, or if your dog shows any signs of respiratory distress, euthanasia may be recommended
  • Seizures or paralysis: If cancer spreads to the brain or spinal cord, seizures or paralysis may develop. Consider euthanasia before seizures become severe
  • Pain, nausea, and general distress: If your dog appears to be in pain, vomits frequently, has a poor appetite, seems lethargic, and generally does not feel well, euthanasia may be the most compassionate choice
  • Loss of normal function: When your dog can no longer perform basic activities or enjoy interactions that made life meaningful
  • Uncontrollable bleeding: Frequent or unmanageable hemorrhage episodes that compromise quality of life

Having conversations with your veterinarian about your dog’s quality of life and what you consider acceptable decline can help guide end-of-life decisions. Many veterinarians can assess your individual dog’s situation and provide guidance based on their experience with hemangiosarcoma.

Frequently Asked Questions About Hemangiosarcoma

Q: Can hemangiosarcoma be prevented?

A: Unfortunately, there is no known way to prevent hemangiosarcoma in dogs. The disease develops spontaneously without identified preventive factors. However, maintaining your dog’s overall health through proper nutrition, regular veterinary checkups, and monitoring for early signs of illness may help catch other health issues early.

Q: How is hemangiosarcoma different from other types of dog cancer?

A: Hemangiosarcoma is uniquely aggressive because it develops in blood vessel linings and frequently causes internal bleeding. Many dogs show no symptoms until the disease is advanced, making early detection challenging. Other cancers may have more predictable symptoms or be more amenable to treatment.

Q: Is hemangiosarcoma genetic or hereditary?

A: While certain breeds like Golden Retrievers, German Shepherds, and Labrador Retrievers show higher incidence rates, the exact genetic basis for hemangiosarcoma susceptibility is not fully understood. There is no definitive hereditary pattern, though genetic predisposition may play a role in certain breed lines.

Q: Will my dog be able to recover from hemangiosarcoma surgery?

A: Dogs typically recover from hemangiosarcoma surgery within about two weeks. However, the bigger concern is that hemangiosarcoma frequently metastasizes (spreads) to other locations in the body even after surgery, so surgical recovery is just the first step in managing the disease. Following surgery with chemotherapy may extend survival and quality of life.

Q: What are the side effects of chemotherapy for hemangiosarcoma?

A: Most dogs tolerate chemotherapy for hemangiosarcoma very well with minimal side effects. When side effects do occur, they may include nausea, loss of appetite, or mild lethargy. Severe side effects are uncommon because the dosages used in veterinary medicine are different from those used in human cancer treatment.

Q: How often will my dog need veterinary visits if undergoing chemotherapy?

A: Dogs receiving chemotherapy typically need visits every 2-3 weeks for treatment administration and monitoring. Your veterinarian will also recommend blood work and imaging studies to assess response to treatment and monitor for side effects. The specific schedule will depend on your dog’s individual treatment plan.

Q: Is there any alternative or complementary treatment for hemangiosarcoma?

A: Some alternative approaches like Yunnan Baiyao (a Chinese herbal supplement), acupuncture, and bioactive mushroom extracts are sometimes recommended alongside conventional treatment, though scientific evidence supporting their effectiveness is limited. Always discuss any complementary treatments with your veterinarian before using them.

References

  1. Hemangiosarcoma In Dogs — Paws At Peace. https://pawsatpeace.com/hemangiosarcoma-in-dogs/
  2. Hemangiosarcoma in Dogs — Colorado State University Animal Cancer Center. https://www.csuanimalcancercenter.org/2020/02/28/hemangiosarcoma-in-dogs/
  3. Hemangiosarcoma in Dogs — Cornell University College of Veterinary Medicine. https://www.vet.cornell.edu/departments-centers-and-institutes/riney-canine-health-center/canine-health-information/hemangiosarcoma-dogs
  4. Diagnosis, Prognosis, and Treatment of Canine Hemangiosarcoma — PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC10093745/
  5. Hemangiosarcoma in Dogs — PetMD. https://www.petmd.com/dog/conditions/cancer/hemangiosarcoma-dogs
  6. Hemangiosarcoma in Dogs: Signs, Symptoms, and Treatment — American Kennel Club. https://www.akc.org/expert-advice/health/hemangiosarcoma-in-dogs/
Sneha Tete
Sneha TeteBeauty & Lifestyle Writer
Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to fluffyaffair,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete